Environmental links to early deliveries. by Barrett, Julia R
According to the National Center for
Health Statistics, nearly 12% of U.S.
babies—more than 460,000 infants—are
born prematurely each year, a proportion
that has been steadily increasing for about
a decade. Research published in the
September 2001 issue of the Annals of the
New York Academy of Sciences associates
preterm birth—defined as being born prior
to the 37th week of gestation—with 70%
of newborn deaths and possibly as much as
75% of newborn health complications.
These complications include respiratory
problems, bleeding in the brain, infections,
and poor growth, all of which can under-
mine health and development throughout
childhood. Some consequences can be life-
long: compared to full-term infants,
infants born too soon are at greater risk for
conditions such as cerebral palsy, impaired
vision, deafness, and mental retardation. 
Researchers have sought the causes for
preterm birth with the eventual goal of pre-
dicting and preventing it. Toward that end,
a workshop titled “The Role of Envi-
ronmental Toxicants in Premature Birth”
was sponsored by the Institute of Medicine’s
Roundtable on Environmental Health
Sciences, Research, and Medicine, which in
turn is sponsored by the NIEHS. At the
meeting, held 2–3 October 2001, presenters
reviewed current knowledge about preterm
birth and zeroed in on environmental toxi-
cants as a potential risk factor.
“We don’t know a lot about what caus-
es preterm birth,” admits presenter David
Savitz, chairman of the department of epi-
demiology at the University of North
Carolina School of Public Health in
Chapel Hill. “From what little we do
know, it is very likely that there are multi-
ple contributing factors, and it is very
unlikely that we’re going to stumble across
a single, overwhelming, predominant
determinant of this,” he says. Additionally,
the strongest predictors that have been
identified cannot necessarily be remedied,
such as a history of prior preterm birth or
pregnancies with twins or other multiples.
Race and ethnicity, tobacco smoke, and
uterine infection may also be predictors,
but environmental toxicants have been lit-
tle explored, says Savitz.
According to Matthew Longnecker, an
NIEHS epidemiologist who spoke at the
workshop, the first glimmerings that envi-
ronmental toxicants might factor in
preterm birth appeared in two DDT stud-
ies in the early 1970s. However, the ques-
tion was not pursued: “Right about the
time that an association between the DDT
metabolite DDE and preterm birth was
first reported in humans and then in sea
lions, the environmental movement had
gained enough momentum as a result of
[Rachel Carson’s 1962 book] Silent Spring
that it was agreed that DDT should be
phased out,” Longnecker explains. “It’s
only recently, in the last ten years, that
there has been a steady stream of epidemio-
logic studies looking at risk factors for
preterm birth.” The focus on environmen-
tal toxicants is even more recent.
A Proliferation of Challenges
Environmental toxicants could potentially
be disruptive at any point during pregnan-
cy, each phase of which is regulated by a
cascade of hormones and other endoge-
nous chemicals. During pregnancy, certain
endogenous chemicals maintain uterine
quiescence, or nonactivity. In late pregnan-
cy, others trigger genetic, molecular, and
cellular shifts to prepare the uterus for the
powerful hormone-driven contractions of
birth. Despite intense study, however,
knowledge gaps remain with regard to
human pregnancy. Chandrasekhar
Yallampalli, a professor of obstetrics and
gynecology at the University of Texas
Medical Branch in Galveston, is one of
many researchers seeking to fill these gaps. 
At the workshop, Yallampalli described
his research focusing on nitric oxide (NO),
which may have a role in human uterine
quiescence. In animal studies, Yallampalli
and his colleagues have shown that NO
produced in the uterus during pregnancy
maintains quiescence. Disruption of the
NO system by environmental toxicants
could potentially trigger preterm birth.
There is currently no evidence for this,
however (researchers aren’t even in total
agreement that the NO pathway exists in
human pregnancy), and Yallampalli notes
that a complicating factor lies in translat-
ing the results of animal studies to
humans, for whom only indirect evidence
can be gathered.
There are several big differences
between rats and humans with regard to
pregnancy, he continues. For example, rats
have a high progesterone dependency for
maintaining pregnancy, but humans do
not. In the same way, NO synthesis may
be important in rat pregnancy, but not in
human pregnancy. “In humans, there are a
couple of studies using nitric oxide . . . to
prevent or reduce preterm labor or to pro-
long the duration of labor once preterm
labor has been initiated,” says Yallampalli.
But these studies do not confirm whether
NO actually functions as a quiescent agent
in the human uterus, as in the rat uterus. 
The animal–human differences extend
beyond progesterone, adds speaker Jack
Bishop, an NIEHS research geneticist. For
example, not only is the length of gestation
dramatically different, but rats and mice
will resorb fetuses rather than deliver them
prematurely. Consequently, the animals
that are most easily used in toxicologic
testing—rats and mice—are often not the
best models for human pregnancy. Other
animal models may be more representative,
but none are completely ideal.
In epidemiologic studies of pregnancy,
the challenges are not unlike those in many
other areas of epidemiologic inquiry, says
Longnecker. “Many different factors affect
risk, and exposures with large effects are
the exception—meaning that large studies
are needed to detect effects with preci-
sion,” he says. Characterizing exposure is
especially difficult because questionnaires
by themselves ascertain only fragments of
the information needed, he adds. However,
studying pregnancy outcomes has at least
one advantage compared with other epi-
demiologic inquiries: prospective studies
are relatively more feasible because of the
short time frame of human gestation.
Burgeoning Support from Research
Based on his own and others’ research,
Longnecker says there is some suggestive,
though not conclusive, evidence for envi-
ronmental toxicants triggering preterm
birth. Studies on community-level air pol-
lution suggest a modest association with
preterm birth. 
In a study published in the 14 July 2001
issue of The Lancet, Longnecker and col-
leagues drew on data gathered through the
National Collaborative Perinatal Project
between 1959 and 1966 to investigate
whether exposure to DDE and preterm
birth are related. Through blood sample
analysis, the researchers determined DDE
exposure of mothers enrolled in the project
and compared those results to the gestational
age and birth weight of 2,380 of their chil-
dren. A statistically significant relationship
was uncovered, though Longnecker cautions
that more research is needed. In line with
that need, Longnecker’s current research
focuses on the effects of DDT/DDE in a
highly exposed Mexican population of preg-
nant women and their offspring.
Another area in which environmental
toxicants and preterm birth have been
linked is gene–environment interactions.
Again, though, caution is advised in read-
ing too much into initial results. “Studying
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Environmental Links to Early
Deliveriescomplex gene–environment interactions is
a daunting task,” warns speaker Xiaobin
Wang, an associate professor in pediatrics
at Boston University School of Medicine.
“The ability of an individual to convert
environmental toxicants to less harmful
moieties is important for minimizing their
adverse health effects,” she explains. 
This conversion often occurs in two
parts: phase I and phase II. Phase I
enzymes activate a toxicant, transforming
it into an intermediate that is converted
by phase II enzymes into an excretable
form. Characteristic enzymes of each
phase, such as aryl hydrocarbon hydroxy-
lase in phase I and glutathione-S-trans-
ferase in phase II, are encoded by genes
that are highly variable.
As a consequence of this variability,
aryl hydrocarbon hydroxylase (encoded by
the CYP1A1 gene) and glutathione-S-
transferase (encoded by the GSTT1 gene)
work either more or less effectively at clear-
ing toxicant intermediates, depending on
the individual. In two studies—one involv-
ing benzene exposure, the other tobacco
smoke exposure—Wang and her colleagues
found significant relationships between
preterm birth and certain CYP1A1 and
GSTT1 variations. “[However,] we have
only touched the tip of the iceberg,” says
Wang of her group’s findings. “The issues
of genetic susceptibility and gene–
environment interactions are only begin-
ning to be explored.”
Post-Term Research Endeavors 
According to workshop participants, there
are many new and continuing explorations
ahead. “My ideal goal would be to find
some biomarker that we could extrapolate
between the rodents and humans,” says
Bishop. Should such a biomarker be found,
testing could be incorporated into current
toxicologic protocols. Savitz suggests look-
ing at environmental agents that operate
through suspected mechanisms of preterm
birth; for example, through some aspect of
inflammation demonstrated by infection. 
Longnecker adds that epidemiologic
data could be gathered through the
National Children’s Study of Environ-
mental Effects on Child Health and
Development, a joint effort of the NIEHS,
the National Institute of Child Health and
Human Development, the Centers for
Disease Control and Prevention, and the
U.S. Environmental Protection Agency.
“[The National Children’s Study] is envi-
sioned as a prospective study, beginning
early in pregnancy, of one hundred thou-
sand pregnant women and their families to
study the effect of environmental [agents]
on the full spectrum of health,”
Longnecker explains. “While the data to be
collected are still being considered, it is
anticipated that detailed exposure assess-
ment and collection of biomarkers will
allow an especially close look at environ-
mental contaminants and preterm birth,
among other outcomes.”
Multidisciplinary collaborations will be
a vital component for future research.
“Until recently, the little bit that has been
done looking at environmental factors in
preterm birth has mostly been either dis-
mally poor on the environmental exposure
assessment or on the assessment of the
pregnancy outcome,” says Savitz. Studies in
this field would benefit from expertise in
epidemiology, environmental measure-
ments, toxicology, clinical obstetrics, and
biostatistics, he says. Wang adds that other
welcome collaborators would have expertise
in genetics, molecular biology, bioinfor-
matics, biotechnology, social sciences, and
ethics. “The main part that really has to be
there is the combined sophistication about
the exposure variable and the health out-
come variable,” notes Savitz.
Workshop participants emphasize that
much more work remains to be done. “It’s
just starting,” Bishop summarizes. “This is
a major health problem, so it’s important
enough to try to find some indicators for
environmental causes. There does seem to
be some validity to the thinking that there
may be environmental causes. We just need
to get our models better.” –Julia R. Barrett
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Preemies and possibilities. New research efforts are examining the potential links between environmental exposures of mothers and developing
fetuses and subsequent premature birth.
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